The LEAD Model is built around “high-needs” patients — and that phrase is about to get used loosely across a lot of strategy decks. So let me be precise, because the distinction has operational teeth.
A high RAF score and a high-needs patient are not the same thing, and an organization that conflates them will misallocate the exact resources LEAD is designed to reward.
- Risk scores measure documented disease. High-needs is about life.
A RAF score tells you what a patient has been coded for. It doesn’t tell you whether they can get to the pharmacy.
HCC-based risk captures diagnosed clinical burden. High-needs — the frail, the multiply chronic, the dually eligible, the homebound — is a function of clinical complexity layered on functional and social reality.
A patient can carry a modest RAF and still be profoundly high-needs because they are isolated, food-insecure, and unable to manage a five-drug regimen alone. The code misses all of that.
- Why this matters more under LEAD
LEAD integrates high-needs beneficiaries across every ACO and applies concurrent risk adjustment plus a separate spending trend to them. That is CMS acknowledging these patients do not behave like the standard population.
But the model can only adjust for the high-needs patients you actually identify as such. Under-identify them, and you have taken on their cost without the benchmark accommodation built to offset it.
- The signals that define high-needs aren’t in claims
Functional status — can the patient bathe, ambulate, prepare a meal? Caregiver presence. Housing stability. Cognitive decline. These are the variables that separate a stable chronic patient from a high-needs one, and most never reach a claim.
It is the same lesson as rising-risk identification, sharpened: the defining data lives in assessments and notes, not billing. Social risk is a case in point — SDOH Z-code documentation has historically run in the low single digits as a share of encounters, even as these factors drive avoidable utilization.
- Operationalizing a high-needs definition
A usable definition layers three things: clinical complexity (conditions, polypharmacy), functional status (activities of daily living, mobility, cognition), and social context (dual eligibility, isolation, housing, transportation).
An organization that captures those systematically — through structured assessment, not just coding — can both target care correctly and defend its risk adjustment. One that relies on RAF alone will chase the wrong patients and leave money and outcomes on the table.
- The dual-eligible blind spot
Dually eligible beneficiaries sit at the center of LEAD’s design and at the seam between two programs that rarely share data. Identifying and coordinating their care requires reconciling Medicare and Medicaid information most organizations have not integrated.
LEAD’s two-state Medicaid partnership pilot is a tacit admission of how hard this is. Organizations serious about high-needs care should be building that data capability now, regardless of the pilot.
Final Thoughts
“High-needs” is becoming a strategy buzzword exactly as a ten-year model makes it a financial reality.
As someone trained as a physician who later worked in coding and audit, I’d offer this: the risk score and the patient’s lived complexity are different measurements, and the gap between them is precisely where high-needs care succeeds or fails. Identify these patients by their reality, not just their codes — the model is built to reward you for it.
If your high-needs strategy starts and ends with RAF scores, you’re identifying the wrong population for the model you’re entering. At HealtheNomics, we help organizations build high-needs identification that combines clinical, functional, and social complexity — so targeting and risk adjustment finally align.
Explore the services: https://healthenomics.com/services-2/
Request a strategy conversation: https://healthenomics.com/contact-us/
Connect on LinkedIn: https://www.linkedin.com/in/muhammad-ayoub-ashraf/
Website: https://www.drayoubashraf.com
Watch on YouTube: https://www.youtube.com/@HealtheNomics
